Eli Lilly’s big GLP-1 investment — plus, what we want from 4 portfolio stock earnings

Health, Fitness & Food

Products You May Like

Articles You May Like

Digital health company Noom to offer compounded GLP-1 drug through new weight loss program
Eli Lilly says it will invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer’s drugs
7 Essential Oil Diffusers For When You Need Some Self-Care
How To Meal Prep For Weight Loss For Beginners (LOSE THE WEIGHT!)
Gilead says its twice-yearly shot cut HIV infections by 96% in trial

Leave a Reply

Your email address will not be published. Required fields are marked *